Select Page

Multiple Sclerosis (MS)

For information on Multiple Sclerosis clinical trials, please contact Sonia Lai.

 

Current Recruiting Studies

 

Biogen 109MS401 RRMS (ESTEEM)

A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)

 

Novartis CFT2403 RRMS (PASSAGE)

Long term, prospective, multinational, parallel-cohort study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another approved disease-modifying therapy

 

Genzyme (PASS) Phase IV OBS

A prospective, multicenter, observational post-authorization safety study to evaluate the long term safety profile of lemtrada® (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis

Biogen 215MS202 (AFFINITY)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multiple Sclerosis to Evaluate the Efficacy and Safety of BIIB033 as an Add-On Therapy to Anti-Inflammatory Disease-Modifying Therapies

 
Sanofi OBS14527(LEM-COG)

A Prospective 24-Month Observational Study to Evaluate Neurocognitive Function and Safety in Patients with Relapsing Multiple Sclerosis Who Are Initiating LEMTRADA® Treatment in Routine Clinical Practice